FibroGen, Inc.
FGEN
$0.2912
-$0.0269-8.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 205.26% | -9.91% | 52.80% | 41.43% | 11.61% |
| Total Depreciation and Amortization | -52.37% | -5.38% | -4.76% | -56.27% | -21.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -107.82% | 140.75% | -21.12% | -26.62% | -16.84% |
| Change in Net Operating Assets | -837.95% | 83.32% | 10.34% | -227.73% | 177.11% |
| Cash from Operations | -263.73% | 78.99% | 32.75% | -223.61% | 78.33% |
| Capital Expenditure | -71.95% | -485.71% | 51.72% | 88.45% | 63.30% |
| Sale of Property, Plant, and Equipment | -75.39% | 27,800.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 40.82% | 388.95% | -80.89% |
| Cash from Investing | 128.21% | -98.95% | 40.88% | 400.64% | -81.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 75.00% | -100.00% | 33.33% | 77.78% | -145.45% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | 87.39% | -46.05% | 50.33% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.94% | -496.88% | 119.39% | 32.93% | -1,018.18% |
| Foreign Exchange rate Adjustments | 95.57% | -176.14% | 1,056.05% | -79.71% | 182.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -196.83% | -127.76% | 539.78% | -10.07% | 77.18% |